logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Takeda Vaccines, Inc.


USPTO Granted Patents = 69



Forward Citations = 212

Loading Chart...
Loading Chart...

46 inventors (with patents filed for the assignee):

goldMedal Dan T Stinchcomb (24 out of 57 patents)

silverMedal Jill Ann Livengood (20 out of 20 patents)

bronzeMedal Charles Richardson (19 out of 22 patents)

4.  Jorge E Osorio (18 out of 23 patents)

5.  Thomas R Foubert (17 out of 20 patents)

6.  Thomas S Vedvick (13 out of 49 patents)

7.  William T Tino (10 out of 17 patents)

8.  Joel R Haynes (9 out of 11 patents)

9.  Timothy D Powell (7 out of 7 patents)

10.  Joseph N Brewoo (7 out of 7 patents)

11.  Claire Kinney (6 out of 7 patents)

12.  Richard M Kinney (6 out of 19 patents)

13.  Bryan Steadman (6 out of 7 patents)

14.  Hansi Dean (6 out of 6 patents)

15.  Charalambos D Partidos (5 out of 5 patents)


Core Competencies:
Virus Like Particles
Dengue Vaccines
Hepatitis A
Zika Vaccines
Norovirus Vaccines
Flavivirus Stabilization
Live Attenuated Viruses
Pharmaceutical Packaging
Immunogenic Compositions
Chimeric Virus Constructs
Rhabdovirus Detection
Alphavirus Formulations

69 patents:

1. 12286456 - Purification of virus like particles (2025-04-29),
2. 12201683 - Methods for preventing dengue and hepatitis a (2025-01-21),
3. 12186363 - Compositions and methods for dengue virus chimeric constructions in vaccines (2025-01-07),
4. D1054846 - Pharmaceutical packaging (2024-12-24),
5. 12109260 - Zika vaccines and immunogenic compositions, and methods of using the same (2024-10-08),
6. 12018052 - Methods of detection and removal of rhabdoviruses from cell lines (2024-06-25),
7. 12006341 - Methods of detection and removal of rhabdoviruses from cell lines (2024-06-11),
8. 11975062 - Zika vaccines and immunogenic compositions, and methods of using the same (2024-05-07),
9. 11964008 - Method for inactivating zika virus and for determining the completeness of inactivation (2024-04-23),
10. 11931399 - Compositions and methods for dengue virus chimeric constructions in vaccines (2024-03-19),
11. 11826415 - Method of conferring a protective immune response to Norovirus (2023-11-28),
12. 11730802 - Zika vaccines and immunogenic compositions, and methods of using the same (2023-08-22),
13. 11701421 - Compositions and methods for stabilizing flaviviruses with improved formulations (2023-07-18),
14. 11701420 - Parenteral norovirus vaccine formulations (2023-07-18),
15. 11648304 - Zika vaccines and immunogenic compositions, and methods of using the same (2023-05-16),
Takeda Vaccines, Inc. is a leading pharmaceutical company focused on research and development of vaccines. With a mission to improve human health, Takeda Vaccines is dedicated to developing innovative solutions to prevent and treat infectious diseases. Their portfolio includes vaccines for various conditions, including Zika virus, dengue fever, and the COVID-19 pandemic. Takeda Vaccines is committed to providing safe and effective vaccines that contribute to global health security.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
69 Patents

#35 in Cambridge, MA

#285 in Massachusetts

#5,129 in US

#10,481 in the World

...
Cambridge, MA, United States of America

Takeda Vaccines, Inc.

Forward Citations = 212

46 inventors:

goldMedal Dan T Stinchcomb (24 out of 57 patents)

silverMedal Jill Ann Livengood (20 out of 20 patents)

bronzeMedal Charles Richardson (19 out of 22 patents)

4.  Jorge E Osorio (18 out of 23 patents)

5.  Thomas R Foubert (17 out of 20 patents)

Please report any incorrect information to support@idiyas.com
Loading…